Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

A rationale for early extracorporeal membrane oxygenation in patients with postinfarction ventricular septal rupture complicated by cardiogenic shock

D. Rob, R. Špunda, J. Lindner, V. Rohn, J. Kunstýř, M. Balík, J. Rulíšek, P. Kopecký, M. Lipš, O. Šmíd, T. Kovárník, F. Mlejnský, A. Linhart, J. Bělohlávek,

. 2017 ; 19 Suppl 2 (-) : 97-103.

Language English Country Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

AIMS: Ventricular septal rupture (VSR) became a rare mechanical complication of myocardial infarction in the era of percutaneous coronary interventions but is associated with extreme mortality in patients who present with cardiogenic shock (CS). Promising outcomes have been reported with the use of circulatory support allowing haemodynamic stabilization, followed by delayed repair. Therefore, we analysed our experience with an early use of Veno-Arterial Extracorporeal Membrane Oxygenation (V-A ECMO) for postinfarction VSR. METHODS AND RESULTS: We conducted a retrospective search of institutional database for patients presenting with postinfarction VSR from January 2007 to June 2016. Data from 31 consecutive patients (mean age 69.5 ± 9.1 years) who were admitted to hospital were analysed. Seven out of 31 patients with VSR who were in refractory CS received V-A ECMO support preoperatively. ECMO improved end-organ perfusion with decreased lactate levels 24 hours after implantation (7.9 mmol/L vs. 1.6 mmol/L, p = 0.01), normalized arterial pH (7.25 vs. 7.40, p < 0.04), improved mean arterial pressure (64 mmHg vs. 83 mmHg, p < 0.01) and lowered heart rate (115/min vs. 68/min, p < 0.01). Mean duration of ECMO support was 12 days, 5 out of 7 patients underwent surgical repair, 4 were weaned from ECMO, 3 survived 30 days and 2 survived more than 1 year. The most frequent complication (5 patients) and the cause of death (3 patients) was bleeding. CONCLUSIONS: Our experience suggests that early V-A ECMO in patients with VSR and refractory CS might prevent irreversible multiorgan failure by improved end-organ perfusion. Bleeding complications remain an important limitation of this approach.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18010602
003      
CZ-PrNML
005      
20180528160638.0
007      
ta
008      
180404s2017 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1002/ejhf.852 $2 doi
035    __
$a (PubMed)28470920
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Rob, Daniel $u 2nd Department of Medicine - Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
245    12
$a A rationale for early extracorporeal membrane oxygenation in patients with postinfarction ventricular septal rupture complicated by cardiogenic shock / $c D. Rob, R. Špunda, J. Lindner, V. Rohn, J. Kunstýř, M. Balík, J. Rulíšek, P. Kopecký, M. Lipš, O. Šmíd, T. Kovárník, F. Mlejnský, A. Linhart, J. Bělohlávek,
520    9_
$a AIMS: Ventricular septal rupture (VSR) became a rare mechanical complication of myocardial infarction in the era of percutaneous coronary interventions but is associated with extreme mortality in patients who present with cardiogenic shock (CS). Promising outcomes have been reported with the use of circulatory support allowing haemodynamic stabilization, followed by delayed repair. Therefore, we analysed our experience with an early use of Veno-Arterial Extracorporeal Membrane Oxygenation (V-A ECMO) for postinfarction VSR. METHODS AND RESULTS: We conducted a retrospective search of institutional database for patients presenting with postinfarction VSR from January 2007 to June 2016. Data from 31 consecutive patients (mean age 69.5 ± 9.1 years) who were admitted to hospital were analysed. Seven out of 31 patients with VSR who were in refractory CS received V-A ECMO support preoperatively. ECMO improved end-organ perfusion with decreased lactate levels 24 hours after implantation (7.9 mmol/L vs. 1.6 mmol/L, p = 0.01), normalized arterial pH (7.25 vs. 7.40, p < 0.04), improved mean arterial pressure (64 mmHg vs. 83 mmHg, p < 0.01) and lowered heart rate (115/min vs. 68/min, p < 0.01). Mean duration of ECMO support was 12 days, 5 out of 7 patients underwent surgical repair, 4 were weaned from ECMO, 3 survived 30 days and 2 survived more than 1 year. The most frequent complication (5 patients) and the cause of death (3 patients) was bleeding. CONCLUSIONS: Our experience suggests that early V-A ECMO in patients with VSR and refractory CS might prevent irreversible multiorgan failure by improved end-organ perfusion. Bleeding complications remain an important limitation of this approach.
650    _2
$a senioři $7 D000368
650    _2
$a angiografie $7 D000792
650    _2
$a mimotělní membránová oxygenace $x metody $7 D015199
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a následné studie $7 D005500
650    _2
$a hemodynamika $x fyziologie $7 D006439
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a rizikové faktory $7 D012307
650    _2
$a kardiogenní šok $x etiologie $x patofyziologie $x terapie $7 D012770
650    _2
$a výsledek terapie $7 D016896
650    _2
$a ruptura komorového septa $x komplikace $x diagnóza $x patofyziologie $7 D018658
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Špunda, Rudolf $u 2nd Surgery Department - Department of Cardiovascular Surgery, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
700    1_
$a Lindner, Jaroslav $u 2nd Surgery Department - Department of Cardiovascular Surgery, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
700    1_
$a Rohn, Vilém $u Cardiovascular Surgery Department, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic.
700    1_
$a Kunstýř, Jan $u Department of Anesthesiology and Intensive Care, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
700    1_
$a Balík, Martin $u Department of Anesthesiology and Intensive Care, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
700    1_
$a Rulíšek, Jan $u Department of Anesthesiology and Intensive Care, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic. $7 xx0224602
700    1_
$a Kopecký, Petr $u Department of Anesthesiology and Intensive Care, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
700    1_
$a Lipš, Michal $u Department of Anesthesiology and Intensive Care, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
700    1_
$a Šmíd, Ondřej $u 2nd Department of Medicine - Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
700    1_
$a Kovárník, Tomáš $u 2nd Department of Medicine - Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
700    1_
$a Mlejnský, František $u 2nd Surgery Department - Department of Cardiovascular Surgery, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
700    1_
$a Linhart, Aleš $u 2nd Department of Medicine - Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
700    1_
$a Bělohlávek, Jan $u 2nd Department of Medicine - Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
773    0_
$w MED00006634 $t European journal of heart failure $x 1879-0844 $g Roč. 19 Suppl 2, č. - (2017), s. 97-103
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28470920 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180404 $b ABA008
991    __
$a 20180528160830 $b ABA008
999    __
$a ok $b bmc $g 1288087 $s 1007414
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 19 Suppl 2 $c - $d 97-103 $i 1879-0844 $m European journal of heart failure $n Eur J Heart Fail $x MED00006634
LZP    __
$a Pubmed-20180404

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...